Inventor · disambiguated record
Terrence J. Hunt
Also filed as: HUNT TERRENCE · HUNT TERRENCE J
29 granted patents·31 pending applications·671 citations·filing 1994–2023
98Inventor score
Top patents by PatentIndex Score
60 records- 0199US8168206B1Animal protein-free pharmaceutical compositionsHUNT TERRENCE J·Filed 2008·Granted May 1, 2012·52 cites·12 claims
- 0298US11285216B2Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2021·Granted Mar 29, 2022·4 cites·23 claims
- 0398US11033625B2Method for stabilizing a toxinALLERGAN INC·Filed 2020·Granted Jun 15, 2021·5 cites·19 claims
- 0498US7758873B2Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereofALLERGAN INC·Filed 2005·Granted Jul 20, 2010·32 cites·18 claims
- 0597US11147878B2Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2021·Granted Oct 19, 2021·3 cites·21 claims
- 0697US9278140B2Sustained release poloxamer containing pharmaceutical compositionsALLERGAN INC·Filed 2015·Granted Mar 8, 2016·21 cites·9 claims
- 0797US8642047B2Non-protein stabilized Clostridial toxin pharmaceutical compositionsHUNT TERRENCE J·Filed 2012·Granted Feb 4, 2014·36 cites·9 claims
- 0897US8632785B2Clostridial toxin pharmaceutical composition containing a gelatin fragmentHUNT TERRENCE J·Filed 2005·Granted Jan 21, 2014·35 cites·7 claims
- 0997US8216591B2Pharmaceutical compositions containing botulinum toxinHUNT TERRENCE J·Filed 2006·Granted Jul 10, 2012·22 cites·17 claims
- 1097US8137677B2Non-protein stabilized clostridial toxin pharmaceutical compositionsHUNT TERRENCE J·Filed 2006·Granted Mar 20, 2012·47 cites·12 claims
- 1196US9107815B2Sustained release poloxamer containing pharmaceutical compositionsHUNT TERRENCE J·Filed 2008·Granted Aug 18, 2015·32 cites·5 claims
- 1296US8580250B2Botulinum toxin compositionsHUNT TERRENCE J·Filed 2012·Granted Nov 12, 2013·28 cites·6 claims
- 1396US8501196B2Pharmaceutical compositions containing botulinum neurotoxinHUNT TERRENCE J·Filed 2012·Granted Aug 6, 2013·15 cites·6 claims
- 1496US8323666B2Botulinum toxin compositionsHUNT TERRENCE J·Filed 2005·Granted Dec 4, 2012·31 cites·6 claims
- 1596US7579010B2Botulinum toxin pharmaceutical compositions with a recombinant human serum albuminALLERGAN INC·Filed 2004·Granted Aug 25, 2009·48 cites·14 claims
- 1695US9981022B2Sustained release poloxamer containing pharmaceutical compositionsALLERGAN INC·Filed 2016·Granted May 29, 2018·16 cites·2 claims
- 1795US7780967B2Reduced toxicity Clostridial toxin pharmaceutical compositionsALLERGAN INC·Filed 2003·Granted Aug 24, 2010·40 cites·11 claims
- 1894US9302008B2Pharmaceutical compositions containing botulinum toxinHUNT TERRENCE J·Filed 2007·Granted Apr 5, 2016·14 cites·5 claims
- 1994US9050336B2Botulinum toxin formulationBLANDA WENDY M·Filed 2012·Granted Jun 9, 2015·34 cites·7 claims
- 2093US9943576B2Formulations of biologics for intravesical instillationALLERGAN INC·Filed 2015·Granted Apr 17, 2018·10 cites·9 claims
- 2193US9044477B2Botulinum toxin formulationBLANDA WENDY M·Filed 2007·Granted Jun 2, 2015·30 cites·12 claims
- 2292US9629904B2Botulinum toxin compositionsALLERGAN INC·Filed 2013·Granted Apr 25, 2017·13 cites·16 claims
- 2388US2024165236A1Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2023·Application pending·0 cites
- 2485US11524075B2Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2022·Granted Dec 13, 2022·0 cites·30 claims
- 2585US2024226252A1Method to manufacture a stable proteinALLERGAN INC·Filed 2023·Application pending·0 cites
- 2684US2022370614A1Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2022·Application pending·0 cites
- 2781US2022031846A1Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 2878US11446382B2Animal protein-free pharmaceutical compositionsALLERGAN INC·Filed 2021·Granted Sep 20, 2022·0 cites·30 claims
- 2971US2020330564A1Method to manufacture a stable proteinALLERGAN INC·Filed 2020·Application pending·0 cites
- 3070US2013296259A1Pharmaceutical compositions containing botulinum neurotoxinALLERGAN INC·Filed 2013·Application pending·0 cites
- 3170US2023256063A1Formulations of biologics for intravesical instillationALLERGAN INC·Filed 2022·Application pending·0 cites
- 3269US2009304748A1Clostridial toxin pharmaceutical compositionsALLERGAN INC·Filed 2009·Application pending·0 cites
- 3368US2012207787A1Animal Protein-Free Pharmaceutical CompositionsHUNT TERRENCE J·Filed 2012·Application pending·0 cites
- 3465US2005208076A1Botulinum toxin pharmaceutical composition with enhanced potencyALLERGAN INC·Filed 2005·Application pending·0 cites
- 3565US2005143289A1Botulinum toxin pharmaceutical compositionALLERGAN INC·Filed 2005·Application pending·0 cites
- 3665US2005238667A1Botulinum toxin pharmaceutical compositions with enhanced potency with regard to a reference botulinum toxin pharmaceutical compositionALLERGAN INC·Filed 2005·Application pending·0 cites
- 3763US2014199288A1Pharmaceutical compositions containing botulinum neurotoxinALLERGAN INC·Filed 2014·Application pending·0 cites
- 3862US2014112908A1Non-protein stabilized clostridial toxin pharmaceutical compositionsALLERGAN INC·Filed 2013·Application pending·0 cites
- 3962US2019022195A1Formulations of biologics for intravesical instillationALLERGAN INC·Filed 2018·Application pending·0 cites
- 4062US2003118598A1Clostridial toxin pharmaceutical compositionsALLERGAN INC·Filed 2002·Application pending·0 cites
- 4161US2018271959A1Sustained release poloxamer containing pharmaceutical compositionsALLERGAN INC·Filed 2018·Application pending·0 cites
- 4260US5549894ADisinfecton formulations and methods using D-enantiomeric anti-microbial peptidesALLERGAN INC·Filed 1994·Granted Aug 27, 1996·23 cites·17 claims
- 4358US2017224786A1Botulinum toxin compositionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 4458US2008213315A1Clostridial toxin pharmaceutical compositionsALLERGAN INC·Filed 2008·Application pending·0 cites
- 4556US2006269575A1Botulinum toxin pharmaceutical compositions formulated with recombinant albuminALLERGAN INC·Filed 2006·Application pending·0 cites
- 4654US5897833ASystems and methods for disinfecting contact lensesALLERGAN INC·Filed 1996·Granted Apr 27, 1999·20 cites·15 claims
- 4752US2003138460A1Methods of treating animals with botulinum toxin pharmaceutical compositionsALLERGAN INC·Filed 2003·Application pending·0 cites
- 4850US2021275691A1Screening assay to assess topical delivery of biological therapeutic agentsALLERGAN INC·Filed 2019·Application pending·0 cites
- 4949US5696171AContact lens disinfecting compositions and methods employing terpenesALLERGAN INC·Filed 1994·Granted Dec 9, 1997·30 cites·4 claims
- 5049US2013224178A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopepidasesALLERGAN INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →